Pfizer’s Legal Troubles Over Hormone May Grow
Brandweek
December 2005
When the U.S. Government declined to intervene in a qui tam action against Pfizer, doubts were raised about the merits of the case. However, Brandweek received the real answer from Nolan Auerbach partner Kenneth Nolan. “A perfectly good case can be declined and is declined all the time, sometimes because the government does not have enough time to investigate,” said Nolan.